These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34426944)

  • 1. Does accepted definition of Clostridioides difficile infection (CDI) severity predict poor outcomes in older adults?
    Atamna A; Babich T; Margalit I; Avni T; Ben Zvi H; Raz NE; Yahav D; Bishara J
    Aging Clin Exp Res; 2022 Mar; 34(3):583-589. PubMed ID: 34426944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor functional status as a risk factor for severe Clostridium difficile infection in hospitalized older adults.
    Rao K; Micic D; Chenoweth E; Deng L; Galecki AT; Ring C; Young VB; Aronoff DM; Malani PN
    J Am Geriatr Soc; 2013 Oct; 61(10):1738-42. PubMed ID: 24083842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review on the definition and predictors of severe Clostridiodes difficile infection.
    Zhang VRY; Woo ASJ; Scaduto C; Cruz MTK; Tan YY; Du H; Feng M; Siah KTH
    J Gastroenterol Hepatol; 2021 Jan; 36(1):89-104. PubMed ID: 32424877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frailty level at discharge predicts mortality in older patients with Clostridioides difficile more accurately than age or disease severity.
    Rubak T; Baunwall SMD; Gregersen M; Hansen TK; Rosenbæk JB; Erikstrup LT; Hvas CL; Damsgaard EMS
    Eur Geriatr Med; 2023 Jun; 14(3):583-593. PubMed ID: 37046032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the SHEA/IDSA severity criteria to predict poor outcomes among inpatients and outpatients with
    Stevens VW; Shoemaker HE; Jones MM; Jones BE; Nelson RE; Khader K; Samore MH; Rubin MA
    Infect Control Hosp Epidemiol; 2020 May; 41(5):510-516. PubMed ID: 31996280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.
    Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K
    mBio; 2020 May; 11(3):. PubMed ID: 32371595
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease.
    Ananthakrishnan AN; Guzman-Perez R; Gainer V; Cai T; Churchill S; Kohane I; Plenge RM; Murphy S
    Aliment Pharmacol Ther; 2012 Apr; 35(7):789-95. PubMed ID: 22360370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The outcomes of Clostridioides difficile infection in inpatient liver transplant population.
    Amjad W; Qureshi W; Malik A; Singh R; Jafri SM
    Transpl Infect Dis; 2022 Feb; 24(1):e13750. PubMed ID: 34695277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community versus health care-associated Clostridioides difficile infection: A comparison between clinical characteristics and outcomes in hospitalized patients.
    Ayada G; Atamna A; Babich T; Ben Zvi H; Elis A; Bishara J
    Am J Infect Control; 2023 Dec; 51(12):1339-1343. PubMed ID: 37290688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of
    Milenković B; Šuljagić V; Perić A; Dragojević-Simić V; Tarabar O; Milanović M; Putić V; Tomić D; Miljković B; Vezmar Kovačević S
    Eur J Hosp Pharm; 2022 Mar; 29(e1):e15-e22. PubMed ID: 33579720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Clostridium difficile infection severity in patients hospitalised in medical intensive care.
    Khanafer N; Touré A; Chambrier C; Cour M; Reverdy ME; Argaud L; Vanhems P
    World J Gastroenterol; 2013 Nov; 19(44):8034-41. PubMed ID: 24307797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridioides difficile infection in patients with hematological malignancy: A multicenter study in Taiwan.
    Hung YP; Tsai CS; Tsai BY; Tsai PJ; Lee YT; Lee JC; Liu HC; Hsueh PR; Lee CC; Ko WC
    J Microbiol Immunol Infect; 2021 Dec; 54(6):1101-1110. PubMed ID: 33678554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Clostridioides difficile Infection and Non-compliance with Treatment Guidelines in Adults in 10 US Geographical Locations, 2013-2015.
    Novosad SA; Mu Y; Winston LG; Johnston H; Basiliere E; Olson DM; Farley MM; Revis A; Wilson L; Perlmutter R; Holzbauer SM; Whitten T; Phipps EC; Dumyati GK; Beldavs ZG; Ocampo VLS; Davis CM; Kainer M; Gerding DN; Guh AY
    J Gen Intern Med; 2020 Feb; 35(2):412-419. PubMed ID: 31768906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes in community-acquired Clostridium difficile infection.
    Khanna S; Pardi DS; Aronson SL; Kammer PP; Baddour LM
    Aliment Pharmacol Ther; 2012 Mar; 35(5):613-8. PubMed ID: 22229532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and Outcomes Associated With Clostridioides difficile Infection in Solid Organ Transplant Recipients.
    Hosseini-Moghaddam SM; Luo B; Bota SE; Husain S; Silverman MS; Daneman N; Brown KA; Paterson JM
    JAMA Netw Open; 2021 Dec; 4(12):e2141089. PubMed ID: 34964852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
    Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
    Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology, outcomes, and predictors of mortality in hospitalized adults with Clostridium difficile infection.
    Khanna S; Gupta A; Baddour LM; Pardi DS
    Intern Emerg Med; 2016 Aug; 11(5):657-65. PubMed ID: 26694494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Outcomes in Hospitalized Patients with Clostridium difficile Infection by Age Group.
    Lee HC; Kim KO; Jeong YH; Lee SH; Jang BI; Kim TN
    Korean J Gastroenterol; 2016 Feb; 67(2):81-6. PubMed ID: 26907483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.
    Wombwell E; Patterson ME; Bransteitter B; Gillen LR
    Clin Infect Dis; 2021 Nov; 73(9):e2512-e2518. PubMed ID: 32575126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients.
    Miller R; Morillas JA; Brizendine KD; Fraser TG
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.